NTRA

NTRA Lobbyist: Federal Drug Reform Action Unlikely

Advocates for change in horse racing didn’t find much reason for optimism in the National Thoroughbred Racing Association’s legislative update held in Saratoga Springs Aug. 7. The presentation from lobbyist Greg Means, founder and principal of The Alpine Group in Washington, D.C., reviewed current legislation or proposals that pertain to racing. Included were bills covering…

Medication reform: Two vets’ perspectives

To some observers, the most damning element of the People for the Ethical Treatment of Animals (PETA) video of trainer Steve Asmussen’s barns is that it reveals nothing that violates racing’s medication rules. That video, released in March and covered by The New York Times, purported to show what really goes on behind the scenes of a…

“The Right Thing To Do,” But…: Mid-Atlantic Trainers Talk about Multiple Medication Violation points system

At a July meeting in Saratoga Springs, the Association of Racing Commissioners International (ARCI) approved a model rule described by the organization as the third of three measures designed to address inconsistencies in national medication policies in Thoroughbred horse racing (here). Just about two months later, details of the system have yet to reach the…

Law Panelists Note Progress In Drug Reform

While the topics at this year’s Saratoga Institute on Racing and Gaming Law were similar to those at other industry meetings this summer, the tenor of the presentations and perspectives of the panelists were not. Two days after The Jockey Club Round Table conference, at which chairman Ogden Mills “Dinny” Phipps declared that the organization…